文献速递头颈外科

微创远程入路与传统开放入路在甲状腺全切联合中央颈淋巴结清扫术中的系统评价与Meta分析

Minimally Invasive Remote Approaches Versus Conventional Open Approach in Central Neck Dissection for Patients Undergoing Total Thyroidectomy: A Systematic Review and Meta-Analysis.
PubMed 文献 · Head Neck · 2026-07-21

该系统评价与Meta分析纳入11项比较研究共1626例甲状腺癌患者,比较微创远程入路(MIRA,机器人或内镜)与传统开放入路(COA)行甲状腺全切联合中央颈淋巴结清扫的疗效。结果显示MIRA手术时间显著更长,但暂时性声带麻痹和暂时性甲状旁腺功能减退发生率无显著差异,术中出血、引流量和住院时间相当,MIRA组检出淋巴结数略少。永久性并发症因报告有限无法定量分析,COA仍为参考标准。

要点

  • MIRA行中央颈淋巴结清扫的手术时间显著长于COA(SMD 1.75;95% CI 1.39-2.11)。
  • 暂时性声带麻痹和暂时性甲状旁腺功能减退发生率两组无显著差异。
  • MIRA组检出淋巴结数略少于COA(SMD -0.12;95% CI -0.26至-0.003),效应量小。

核心结论

  • 在严格选择的甲状腺癌患者中,MIRA行甲状腺全切联合中央颈淋巴结清扫可行且安全,术后并发症率与COA相当。
  • 鉴于手术时间更长且长期肿瘤学结局证据有限,COA仍应作为参考标准,MIRA可考虑在专科高容量中心对选择患者使用。

研究设计与样本

  • 遵循PRISMA 2020指南的系统评价与Meta分析,检索PubMed/MEDLINE、Cochrane Library和Scopus截至2025年11月24日。
  • 纳入11项比较研究共1626例接受甲状腺全切联合中央颈淋巴结清扫(单侧或双侧)的甲状腺癌患者。

主要发现

  • MIRA组手术时间显著长于COA(SMD 1.75;95% CI 1.39-2.11)。
  • 暂时性声带麻痹(OR 1.38;95% CI 0.93-2.04)和暂时性甲状旁腺功能减退(OR 0.83;95% CI 0.46-1.49)发生率两组无显著差异。
  • 术中出血量、术后引流量和住院时间两组相当。
  • MIRA组检出淋巴结数略少(SMD -0.12;95% CI -0.26至-0.003),效应量小。
  • 永久性声带麻痹和永久性甲状旁腺功能减退因报告有限且不一致,无法定量分析。

关键数值与推荐

  • 主要结局包括手术时间、暂时性和永久性声带麻痹发生率、暂时性和永久性甲状旁腺功能减退发生率。
  • MIRA组手术时间SMD 1.75(95% CI 1.39-2.11),暂时性声带麻痹OR 1.38(95% CI 0.93-2.04),暂时性甲状旁腺功能减退OR 0.83(95% CI 0.46-1.49),检出淋巴结数SMD -0.12(95% CI -0.26至-0.003)。

临床怎么用

  • COA应继续作为甲状腺全切联合中央颈淋巴结清扫的参考标准。
  • MIRA可在专科高容量中心对严格选择的患者中考虑使用,需权衡更长手术时间与美容获益。

局限性

  • 永久性声带麻痹和永久性甲状旁腺功能减退因报告有限且不一致,无法进行定量分析。
  • 长期肿瘤学结局证据有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Total thyroidectomy (TT) with central neck dissection (CND) is the standard surgical approach in selected thyroid cancer patients. Minimally invasive remote approaches (MIRA), either robotic or endoscopic, have been developed to improve cosmetic outcomes, but their oncological safety and efficacy remain debated. OBJECTIVE: To compare MIRA and the conventional open approach (COA) for CND during TT in terms of surgical outcomes, postoperative complications, and oncologic adequacy. METHODS: Following PRISMA 2020 guidelines, a systematic review and meta-analysis was conducted. PubMed/MEDLINE, Cochrane Library, and Scopus databases were searched up to November 24, 2025. Only comparative studies including TT and CND (either ipsilateral or bilateral) in thyroid carcinoma patients were included. Primary outcomes of interest were differences in operative time, rates of transient and permanent vocal fold paralysis, and incidence of transient and permanent hypoparathyroidism. RESULTS: Eleven comparative studies including 1626 patients were analyzed. MIRA was associated with a significantly longer operative time compared with COA (standardized mean difference (SMD) 1.75; 95% CI 1.39-2.11). No significant differences were observed between the two techniques in terms of transient vocal fold paralysis (OR 1.38; 95% CI 0.93-2.04) or transient hypoparathyroidism (OR 0.83; 95% CI 0.46-1.49). Intraoperative blood loss, postoperative drainage volume, and length of hospital stay were comparable between groups. The number of retrieved lymph nodes was slightly lower in the MIRA group, although the effect size was small (SMD -0.12; 95% CI -0.26 to -0.003). Due to limited and inconsistent reporting, permanent vocal fold paralysis and permanent hypoparathyroidism could not be quantitatively analyzed. CONCLUSION: MIRA for CND during TT appears to be feasible and safe in carefully selected thyroid cancer patients, with postoperative complication rates comparable to those of the COA. However, given the longer operative times and the limited evidence on long-term oncologic outcomes, the COA should remain the reference standard, while MIRA may be considered in selected patients at specialized high-volume centers.

来源:Head Neck,查看原文。版权归原作者所有。

引用

  1. Valenziano C, Costantino A, Sebastiani M, et al. Minimally Invasive Remote Approaches Versus Conventional Open Approach in Central Neck Dissection for Patients Undergoing Total Thyroidectomy: A Systematic Review and Meta-Analysis. Head Neck. 2026. PMID: 42481402. doi:10.1002/hed.70395

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。